Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway

Cell Biochemistry and Function

Volumn 33, Issue 5, 2015, Pages 320-325

  Qu, Yun ^a   Qu, Bo ^a   Wang, Xiaofang ^a   Wu, Rong ^a   Zhang, Xiaoye ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lung cancer; NF B; Small interfering RNA; Xenografts

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; MESSENGER RNA; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; BCLAF1 PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; IN VIVO STUDY; LEWIS LUNG CARCINOMA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; TUMOR XENOGRAFT; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECTS; GENE SILENCING; GENETICS; LEWIS CARCINOMA; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

MUS; MUS MUSCULUS;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; LUNG NEOPLASMS; MICE, INBRED C57BL; MICE, NUDE; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR RELA;

EID: 84937807474     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3117     Document Type: Article

References (35)

1. Miller AV, Hicks MA, Nakajima W, Richardson AC, Windle JJ, Harada H. Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor. PLoS One 2013; 8: e60685.
2. Bhujade A, Gupta G, Talmale S, Das S, Patil M. Induction of apoptosis in A431 skin cancer cells by Cissusquadrangularis Linn stem extract by altering Bax-Bcl-2 ratio, release of cytochrome c from mitochondria and PARP cleavage. Food funct 2013; 4: 338-346.
3. Deyhimi P, Tavakoli P. Study of apoptosis in oral pemphigus vulgaris using immunohistochemical marker Bax and TUNEL technique. J Oral Pathol Med 2012; 42: 409-414.
4. Shapiro M. The role of adjuvant chemotherapy in early-stage and locally advanced non-small cell lung cancer. Cleve Clin J Med 2012; 79: e-S42-e-S45.
5. Chen Y-T, Feng B, Chen L-B. Update of research on drug resistance in small cell lung cancer chemotherapy. Asian Pac J Cancer Prev 2012; 13: 3577-3581.
6. Pore MM, Hiltermann TJN, Kruyt FA. Targeting apoptosis pathways in lung cancer. Cancer Lett 2013; 332: 359-368.
7. Dean EJ, Ranson M, Blackhall F, Holt SV, Dive C. Novel therapeutic targets in lung cancer: inhibitor of apoptosis proteins from laboratory to clinic. Cancer Treat Rev 2007; 33: 203-212.
8. Maloney A, Workman P. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther 2002; 2: 3-24.
9. Sirvent N, Imbert V, Frelin C, Griessinger E, Peyron J. Fighting cancer via NF-kappa B inhibition. Archives de pédiatrie: organe officiel de la Sociéte française de pédiatrie 2003; 10: 632.
10. Haefner B. NF-κB: arresting a major culprit in cancer. Drug Discov Today 2002; 7: 653-663.
11. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6910-6924.
12. Karin M, Cao Y, Greten FR, Li Z-W. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-310.
13. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002; 3: 221-227.
14. Li Z-W, Chu W, Hu Y, et al. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 1999; 189: 1839-1845.
15. Wang X, Chen Y, Ren J, Qu X. Small interfering RNA for effective cancer therapies. Mini Rev Med Chem 2011; 11: 114-124.
16. Verstrepen L, Carpentier I, Verhelst K, Beyaert R. ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling. Biochem Pharmacol 2009; 78: 105-114.
17. Mi J, Zhang X, Rabbani ZN, et al. RNA aptamer-targeted inhibition of NF-κB suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther 2007; 16: 66-73.
18. Ma J, Zhang Z andZhang L. Expression of NF-kappa B and AP-1 in non-small cell lung cancer. Zhongguo fei ai za zhi= Chinese J lung cancer 2005; 8: 440.
19. Tabata M, Ganapathi R. NF-κB activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer. Ann N Y Acad Sci 2000; 922: 343-344.
20. Yu M andLiu X. Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors. Yao xue xue bao= Acta pharmace Sinica 2007; 42: 1007-1012.
21. Mayo MW, Norris JL, Baldwin AS. Ras regulation of NF-kB and apoptosis. Methods Enzymol 2001; 333: 73-87.
22. Farrow S. Death receptors, NF-kappa B activation and apoptosis: the potential for therapeutic intervention. Biochem Soc Trans 1999; 27: 812.
23. Van Antwerp DJ, Martin SJ, Verma IM, Green DR. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol 1998; 8: 107-111.
24. Rushworth SA, Bowles KM, Raninga P, MacEwan DJ. NF-κB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction. Cancer Res 2010; 70: 2973-2983.
25. Kim D-S, Park S-S, Nam B-H, Kim I-H, Kim S-Y. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-κB inactivation. Cancer Res 2006; 66: 10936-10943.
26. Meylan E, Dooley AL, Feldser DM, et al. Requirement for NF-&kgr; B signalling in a mouse model of lung adenocarcinoma. Nature 2009; 462: 104-107.
27. Connelly L, Barham W, Onishko HM, et al. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 2010; 30: 1402-1412.
28. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
29. Tian F, Fan T, Jiang Y, Zhang X, Wang X. A small interfering RNA targeting NF-κB p65 alone or combined with 5-FU inhibits growth of esophageal squamous cell carcinoma in nude mice. Pathol Res Pract 2012; 208: 32-38.
30. Inoue M, Matsumoto S, Saito H, Tsujitani S, Ikeguchi M. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer. Int J Cancer 2008; 123: 2696-2701.
31. Zhu A, Zhou H, Xia J, et al. Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway. Braz J Med Biol Res 2013; 46: 670-675.
32. Cat ZSD, Johnson JL. Transcriptional regulation of Bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 2001; 20(50): 7342-7351.
33. Viatour P, Bentires-Alj M, Chariot A, et al. NF-kappa B2/p100 induces Bcl-2 expression [J]. Leukemia 2003; 17(7): 1349-1356.
34. Akita K, Kawata S, Shimotohno K. p21WAF1 modulates NF-kappa B signaling and induces anti-apoptotic protein Bcl-2 in Tax-expressing rat fibroblast. Virology 2005; 332(1): 249-257.
35. Fahy BN, Schlieman MG, Mortenson MM, et al. Targeting Bcl-2 overexpression in various human malignancies through NF-kappa B inhibition by the proteasome inhibitor bortezomib[J]. Cancer Chemother Pharmacol 2005; 56(1): 46-54.